Company Filing History:
Years Active: 2019-2021
Title: Stefan Lehner - Innovator in Pharmaceutical Solutions
Introduction
Stefan Lehner is a notable inventor based in Germany, recognized for his contributions to the pharmaceutical industry. He has developed innovative solutions that enhance the effectiveness and usability of medications. His work primarily focuses on formulations that improve patient compliance and therapeutic outcomes.
Latest Patents
Stefan Lehner holds two significant patents. The first is for "Low Concentration Meloxicam Tablets," which relates to a solid tablet that is directly compressed from powder. This tablet comprises meloxicam and one or more excipients that are homogenously dispersed within the tablet. It can be broken into two, three, or four units, with each unit containing equal amounts of the active ingredient. The second patent is for an "Oral Suspension Comprising Telmisartan." This invention describes a drinkable pharmaceutical solution of the active substance telmisartan, having a pH above 10. It additionally contains one or more sugar alcohols to improve flavor and shelf life, with a maximum content of 1000 ppm of reducing sugars.
Career Highlights
Stefan Lehner is currently employed at Boehringer Ingelheim Vetmedica GmbH, where he continues to innovate in the field of veterinary medicine. His work has contributed to the development of effective pharmaceutical solutions that cater to the needs of both animals and their owners.
Collaborations
Stefan has collaborated with several professionals in his field, including Martin Andreas Folger and Detlef Mohr. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical technology.
Conclusion
Stefan Lehner is a dedicated inventor whose work in pharmaceutical formulations has the potential to significantly impact patient care. His innovative patents reflect his commitment to improving medication delivery and effectiveness.